Group structure
7 companies in 2 countries
Loading your page…
Loading your page…
7 companies in 2 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 33
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMBENYL12.5mg/5ml; 10mg/5ml · Syrup | Bromodiphenhydramine, Codeine | United States | Not marketed | 1954 |
| BANCAP325mg; 50mg · Capsule | Paracetamol, Butalbital | United States | Not marketed | |
| BANCAP HC500mg; 5mg · Capsule | Paracetamol, Hydrocodone | United States | Not marketed | 1983 |
| BETAPRONESolution | Propiolactone n/a | United States | Not marketed | 1959 |
| CAMPRAL333MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed release | Acamprosate | United States | Not marketed | 2004 |
| CELEXA10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Citalopram | United States | Not marketed | 1999 |
| COMBUNOX400MG; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ibuprofen, Oxycodone | United States | Not marketed | 2004 |
| DURADYNE DHC500mg; 5mg · Tablet | Paracetamol, Hydrocodone | United States | Not marketed | |
| DURAPHYL100mg | 200mg | 300mg · Tablet, extended release | Theophylline | United States | Not marketed | 1985 |
| ELIXICON100mg/5ml · Suspension | Theophylline | United States | Not marketed | |
| ELIXOPHYLLIN100mg | 200mg · Capsule | Theophylline | United States | Not marketed | 1984 |
| ELIXOPHYLLIN SR125mg | 250mg · Capsule, extended release | Theophylline | United States | Not marketed | 1998 |
| ESGIC325mg; 50mg; 40mg · Tablet | Paracetamol, Butalbital, Caffeine | United States | Not marketed | |
| FLUMADINE50mg/5ml · Syrup | Rimantadine | United States | Not marketed | 1993 |
| FORBAXIN750mg · Tablet | Methocarbamol | United States | Not marketed | |
| METRA35mg · Tablet | Phendimetrazine | United States | Not marketed | |
| MICROSUL1GM · Tablet | Sulfamethizole | United States | Not marketed | |
| PROKLAR500mg · Tablet | Sulfamethizole | United States | Not marketed | |
| PYOCIDIN5mg/ml; 10,000 units base/ml · Solution/drops | Hydrocortisone, Polymyxin b | United States | Not marketed | 1972 |
| SULFALOID167mg/5ml; 167mg/5ml; 167mg/5ml · Suspension | Trisulfapyrimidines (sulfadiazine, Sulfamerazine, Sulfamethazine | United States | Not marketed | |
| SULFALOID167mg; 167mg; 167mg · Tablet | Trisulfapyrimidines (sulfadiazine, Sulfamerazine, Sulfamethazine | United States | Not marketed | |
| SUS-PHRINE SULFITE FREE1.5mg/amp | 5mg/ml · Injectable | Epinephrine | United States | Not marketed | 1951 |
| WOLFINA100mg | 50mg · Tablet | Rauwolfia serpentina root | United States | Not marketed | |
| LINZESS | Linaclotide | Saudi Arabia | Authorised | |
| Ubrelvy | Ubrogepant | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 23 | 23 | 0 | CompaniesAll medicines |
| Canada | 8 | 0 | 8 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.